Dyrenium is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Wellspring Pharmaceutical Corporation. The primary component is Triamterene.
Product ID | 65197-002_96d12576-d968-41bc-ad64-fd3812e09f25 |
NDC | 65197-002 |
Product Type | Human Prescription Drug |
Proprietary Name | Dyrenium |
Generic Name | Triamterene |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 1999-10-01 |
Marketing End Date | 2019-12-31 |
Marketing Category | NDA / NDA |
Application Number | NDA013174 |
Labeler Name | WellSpring Pharmaceutical Corporation |
Substance Name | TRIAMTERENE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |
NDC Exclude Flag | N |
Marketing Start Date | 1999-10-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA013174 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1999-10-01 |
Marketing End Date | 2019-12-31 |
Marketing Category | NDA |
Application Number | NDA013174 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-10-11 |
Marketing End Date | 2019-12-31 |
Ingredient | Strength |
---|---|
TRIAMTERENE | 50 mg/1 |
SPL SET ID: | 5012f997-9fb2-4c3d-99fd-4f7efd7c39af |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
59212-002 | Dyrenium | Triamterene |
59212-003 | Dyrenium | Triamterene |
65197-002 | Dyrenium | Triamterene |
65197-003 | Dyrenium | Triamterene |
68151-1494 | Dyrenium | Triamterene |
66993-831 | triamterene | Triamterene |
66993-832 | Triamterene | Triamterene |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DYRENIUM 72193818 0785081 Live/Registered |
SMITH KLINE & FRENCH LABORATORIES 1964-05-19 |